Advanced Enzyme Tech DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.75×	0.72×	0.73×	0.74×
	1.26×	1.23×	1.19×	1.11×	1.16×
	24.4%	25.3%	24.8%	27.1%	22.5%
	0.43×	0.43×	0.40×	0.42×	0.40×
	1.09×	1.09×	1.10×	1.12×	1.11×
	10.8%	10.9%	9.3%	10.3%	8.5%
	11.1%	11.1%	9.6%	10.4%	9.1%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ADVENZYMES₹264.15

Advanced Enzyme Tech Ltd.

· Pharma & Health

₹ CrorePeersAARTIPHARM AARTIDRUGS AGARWALEYE AKUMS ALIVUS APLLTD CORONA HCGMcap ₹2,956 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.74	0.73	0.72	0.75	0.74
Interest Burden (Pretax/EBIT) ×	1.16	1.11	1.19	1.23	1.26
EBIT Margin %	22.46	27.12	24.79	25.34	24.44
Asset Turnover ×	0.40	0.42	0.40	0.43	0.43
Financial Leverage (Assets/Equity) ×	1.11	1.12	1.10	1.09	1.09
ROE (5-step product, year-end total equity) %	8.51	10.33	9.29	10.94	10.76
ROE (owners' profit / average owners' equity) %	9.09	10.42	9.55	11.05	11.05

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.